草药Ninjinyoeito通过调节NF-κB和MAPK通路来抑制RANKL诱导的骨细胞分化和骨再吸收活动
Kaung Htike1, Kunihiro Yoshida2, Takanori Eguchi3
1Department of Dental Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8525, Japan.
Journal of oral biosciences
|October 4, 2024
概括
宁津诺伊伊托 (NYT) 显著抑制骨质细胞分化和功能,为骨质疏松症提供潜在的替代治疗方法. 这种草药抑制了参与骨再吸收的关键信号通路,这表明副作用比传统药物少.
科学领域:
- 骨生物学和新陈代谢
- 药理学和草药医学 药理学和草药医学
背景情况:
- 骨质疏松症是一种与过度骨质细胞 (OC) 活动相关的骨疾病.
- 目前的骨质疏松症治疗有不良影响,例如骨.
- 像Ninjinyoeito (NYT) 这样的草药可能提供更安全的替代品.
研究的目的:
- 为了研究Ninjinyoeito (NYT) 对骨质细胞形成的影响.
- 评估纽约时报作为治疗骨质疏松症的治疗剂的潜力.
主要方法:
- 耐酸酸酶 (TRAP) 染色和骨再吸收试验.
- 分析OC相关的基因表达 (mRNA和蛋白质) 通过西部斑块和RT-PCR.
- 研究信号通路 (IκBα,MAPK,NFATc1,NF-κB p65) 和核转位.
主要成果:
- NYT显著抑制了骨质细胞分化和骨再吸收.
- 纽约时报抑制了与OC相关的基因的mRNA和蛋白质表达.
- 纽约时报废除了IκBα和MAPK信号通路以及NFATc1/NF-κB p65核转位.
结论:
- 宁津诺伊伊托 (NYT) 有效地抑制骨质细胞形成.
- 纽约时报介绍了一个有希望的替代治疗候选人,用于骨质疏松症治疗.
相关概念视频
NF-κB-dependent Signaling Pathway
7.3K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.3K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


